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ABSTRACT 
 
Rapid susceptibility testing of Mycobacterium tuberculosis strains is imperative for therapy 
selection but traditional drug susceptibility tests take weeks or are expensive. Classical drug 
susceptibility (DST) may take up to 2 to 4 months. The line probe assay is a commercially 
available line-probe assay that rapidly detects Mycobacterium tuberculosis (MTB) complex, 
as well as the most common mutations associated with rifampicin and isoniazid. In this study 
we   assessed the sensitivity and specificity of the rapid molecular method in comparison with 
the conventional method. 
  
Introduction 
 
 
Tuberculosis (TB) remains a major health problem in India 
accounting for more than 20 percent of the global incident 
cases[1].  In 2008, the annual incidence was 1.9 million cases, 
of which 0.8 million were infectious new smear positive 
pulmonary TB cases [PTB] cases[2]. Prevalence of MDRTB 
in new cases and previously treated cases is reported as 3% 
and 12-17% respectively [3]. Pulmonary TB can be diagnosed 
by its symptoms, chest radiography, sputum smear microscopy 
and by cultivation of M.tuberculosis, which is considered as 
the gold standard. On a global scale laboratory diagnosis of 
TB principally relies on identification of acid-fast bacilli 
(AFBs) by sputum smear microscopy, which is simple, rapid, 
and economic. Culture of clinical specimens is more sensitive 
than smear microscopy, as only 10-100 viable organisms will 
result in a positive culture while a minimum of 5000-10,000 
acid-fast bacilli (AFB) per ml are required for detection by 
smear.  Identification of M.tuberculosis is done by performing 
several further biochemical tests [4]. In addition isolates 
obtained from cultures can be used for mycobacterial species 
identification, determination of drug susceptibility and 
molecular epidemiology. Although the use of culture has been 
advocated for routine diagnosis, it requires 3-4 weeks to detect 
mycobacterial growth, plus an additional period for 
identification of mycobacterium tuberculosis. Recent advances 
in molecular biology and molecular epidemiology, and a better 
understanding of the molecular basis of drug resistance in TB, 
have provided new tools for rapid diagnosis; however, the 
high cost of most of these techniques, and their requirement 
for sophisticated equipment and skilled personnel have 
precluded their implementation on a routine basis, especially 
in low-income countries. 
A combination of solid and liquid media is currently regarded 
as “gold standard” for primary isolation of mycobacteria, and 
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the turnaround times not exceeding 21 to 30 days after 
specimen collection are recommended for MTB identification 
and drug susceptibility testing . 
There is an urgent need to identify methods that would rapidly 
detect both the presence of Mycobacterium tuberculosis 
[MTB] and drug resistant strains. Culture based methods are 
considered as the gold standard. However, these methods 
require moderate to prolonged incubation time or expensive 
equipment and reagents. Molecular tools perform robustly for 
both detection and drug resistant status determination, in a 
very less time. So this study was conducted to see the 
concordance between the slow conventional and rapid 
molecular method, if rapid method can be adopted in a routine 
basis. 
Drug susceptibility testing (DST) methods include the 
proportion method, the absolute concentration method, and the 
resistance method . 
The GenoType® MTBDRplus assay (Hain Lifescience, 
Nehren, Germany) is a commercially available assay that 
combines detection of MTB complex with prediction of 
resistance to rifampicin and isoniazid. The assay combines 
detection of MTB complex with detection of muitation in the 
81-bp hotspot region of rpoB, at codon 315 of the katG gene 
and in the inhA promoter region. It was found to have high 
sensitivity and specificity for rifampicin and isoniazid 
resistance and performs well when applied directly to AFB-
positive sputum specimens. 
The spread of multiple drug resistant strains of 
Mycobacterium tuberculosis has become a major public health 
concern in both developed and developing countries[5].  
Factors contributing to recent outbreak and continued spread 
of multi drug resistant tuberculosis (MDR-TB) includes 
upsurgence of human immunodeficiency virus (HIV) 
infection/acquired immune deficiency syndrome (AIDS), 
insufficient control procedures and laboratory delays in 
identification and susceptibility testing of M. tuberculosis 
isolates,. 
 
Material and methods 
 
Strains: In this study a total of 342 clinical specimens, both 
respiratory and extrapulmonary, were consecutively received 
for mycobacterial culture in the Department of Medical 
Microbiology, Subharti Medical College, Meerut. Total 147 
(42.98%) were mycobacteria positive, of which 125 (85%) 
were M. tuberculosis and 22 (14.96%) were MOTT 
(mycobacteria other than tuberculosis). MOTT were not 
further characterized/tested. Blood specimens were excluded 
from the study. Investigated specimens included sputa, 
bronchial washings, urine, normally sterile fluids (pleural, 
pericardial, synovial, and cerebrospinal fluids and ascites), 
biopsies, and miscellaneous samples such as pus and gastric 
aspirate specimens. 
Isolation and identification of mycobacteria: Sputum samples 
from each patient was decontaminated, and inoculated on to 
two Lowenstein-Jensen tubes and incubated at 37oC and read 
weekly for eight weeks. No growth after eight week of 
incubation was treated as negative. Growth of M. tuberculosis 
was typed by colony appearance, niacin production, catalase 
activity at 68oC and pH 7 and susceptibility to p-nitrobenzoic 
acid[6]. 
Specimens collected from contaminated sites were liquefied 
and decontaminated by the standard NALC procedure (11). 
After decontamination, all specimens were neutralized with 
phosphate-buffered saline (0.067 M, ph6.8) and centrifuged at 
3,500xg for 20 minutes. The  pellet was used for smear 
preparation (Ziehl-Neelsen staining), culturing and DNA 
extraction, Specimens collected from sterile sites were 
concentrated by centrifugation without prior decontamination. 
For mycobacterial culture, each processed sample (0.5 ml) 
was randomly inoculated into solid media. After inoculation, 
LJ slants were kept for a week with the caps loose, in order to 
enhance sample evaporation, and later tightened. LJ cultures 
were examined visually weekly for up to8 weeks, according to 
standard recommendations. DST for isoniazid (0.2 µg/ml), 
streptomycin (4 µg/ml), ethambutol (2 µg/ml), and rifampicin 
(40 µg/ml) was performed using LJ media following the 
proportion method. 
Microscopy: Smear grading was performed using WHO 
recommendations[7]. Smears were stained by the Ziehl-
Neelsen method to detect mycobacteria. 
Conventional DST on solid media was a standard technology.  
Proportion method:  Drug susceptibility of all positive 
culture isolates to isoniazid (INH), rifampicin (RIF) was 
performed by standard method[8]. Briefly, LJ media with drug 
incorporated in various concentrations and plain LJ medium 
for control were prepared. The growth from a 3-4 weeks old 
culture was scraped with a loop and bacterial suspension was 
made in sterile distilled water, vortexed and matched with 
McFarland opacity tube No. 1. Dilutions of 10-2 and 10-3 were 
made and inoculated on both the control and drug containing 
media and incubated at 370C.  The first reading was taken 
after 28 days of incubation and the second on 40th day.  
They are based on the estimation of growth or no growth of an 
M.tuberculosis strain in the presence of a single critical 
concentration of one drug. The critical concentration of an 
antitubercular drug represents the lowest concentration of the 
drug in the medium that indicates clinically relevant resistance 
if growth is observed. Susceptible wild-type strains are 
inhibited by this concentration. Resistance is defined if over 
1% of the bacterial population of a strain is able to grow. 
GenoType® MTBDRplus assay – Assay was performed on 
smear positive pulmonary samples and culture positive extra-
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pulmonary samples according to the manufacturer’s
instructions. 
 
Result and Discussion 
Concordance between conventional DST and GenoType® 
MTBDRplus assay 
Based on phenotypic DST, 48 strains were M
strains were rifampicin mono-resistant and 44 strains were 
susceptible to all first-line drugs. Considering the phenotypic 
DST method as gold standard, the Line probe assay correctly 
identified 47 of 48 MDR-TB strains (97.9%); 66 of 68 
Table 1: Summary of Results of Multidrug Resistance by GenoType MTBDRplus compared with Conventional drug 
GenoType® MTBDRplus
 
MD
R 
 
 RIF  
monoresista
nce 
 
INH 
monoresistan
ce 
47 19 15 
 
Table 2: Performance of GenoType® MTBDRplus assay in detection of RIF, INH and MDR resistance
 RIF 
Sensitivity 95.58% 
Specificity 98.2% 
PPV (%) 98.48% 
NPV (%) 94.9% 
 
 
 
Figure 1:
Discussion  
 
Cultures on solid media is labor-intensive and it may take 
several weeks for colonies to become detectable; even then, 
the process may require further subculture for definitive 
identification. Multi-drug resistant (MDR) 
tuberculosis isolates may be transmitted within communities 
due to dense population and poor hygiene conditions . In 
general, molecular methods offer several advantages over 
conventional techniques for the rapid detection and 
identification of M.tuberculosis, such as the turn a
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DR-TB, 20  
rifampicin resistant strains (95.58%); 62 of 66 INH resistant 
strains (93.9%). The specificity for detecting MDR
100%. The overall concordance of the GenoType® 
MTBDRplus test and phenotypic test was 91.2% (114/125). 
Sensitivities, specificities and predictive val
Table 1 and 2 
One hundred forty seven mycobacterial isolates grew from 
342 specimens. Of these 342 isolates, 140 (40.9%) were smear 
positive and 202 (59%) were smear negative. The percentage 
of all specimens testing positive for any mycob
42.98%, whereas the MTB isolation rate was 85%.
susceptibility results 
 Conventional DST
 
RIF and 
INH 
sensitive  
 
MD
R  
 
RIF 
monoresistance monoresistance
44 48 20 
culture specimens (N=149) 
INH MDR 
93.9% 97.9% 
99.4% 100% 
98.38% 100% 
92.06% 98.7% 
 
 The specificity for detecting MDR-TB was 100 %. 
Mycobacterium 
round time 
for results, reliability, reproducibility and the possibility to 
improve patient management.
With the 100% specificity of the GenoType® MTBDR
assay to detect MDR in M.tuberculosis isolates, no patient 
would be inappropriately treated with ca
treatment if this test would be used in routine for rapid MDR
TB diagnosis. On the other hand 2% of patients would not 
receive appropriate category 4 treatment (which is based on 
detection of rifampicin resistance) if identification of MD
TB patients is done using only the GenoType® MTBDR
test. These performance characteristics suggest that the assay 
82 
-TB was 
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is equivalent to conventional Lowenstein-Jensen medium-
based DST performed in quality-assured reference laboratories 
Considering that test performs well on the specimens that 
subsequently are contaminated on culture, its overall 
performance for detection of MDR TB is superior to 
conventional methods. None of the molecular tests established 
targets all possible genes or mechanisms (some are not 
identified yet) involved in resistance, and thus, a variable 
proportion of resistant strains will not be detected. 10% 
mutant DNA in a mixture of wild-type and mutant DNA. If 
the proportion of resistant cells in an isolate is less than that 
amount, it can hardly be detected by molecular methods, 
whereas classical susceptibility testing might give a more 
sensitive test result in these cases. Nevertheless, the MTBDR 
culture assay appears to be a valuable tool that allows the 
detection of resistant M.tuberculosis isolates within one 
working day and easily be included in routine workflow. 
Considering the high rates of resistant and MDR isolates in 
several parts of the world, such a test has the potential to 
complement and accelerate the variety of different measures in 
laboratory diagnostics that are necessary for improved 
tuberculosis control in the future. 
Conclusion 
 
Definitive laboratory diagnosis of tuberculosis still revolves 
around the smear examination and culture confirmation for 
M.tuberculosis. Conventional culture confirmation using LJ 
method has the inherent disadvantage of time required to 
observe the growth. This, on many occasions, can delay the 
start of treatment, facilitating spread of the disease, or lead to 
unnecessary treatment of non-specific pulmonary infections. 
Nevertheless, LJ medium remains the gold standard for culture 
and sensitivity testing of MTB. It is useful for (1) early 
confirmation of viable MTB, (2) monitoring response to 
therapy, and (3) monitoring treatment response in multi drug 
resistant tuberculosis. Overall the GenoType® MTBDRplus 
test is a reliable, rapid and easy to perform for the 
simultaneous detection of RMP and INH resistance in M. 
tuberculosis. With high sensitivity for detection of rifampicin 
resistance and high specificity for MDR, we conclude that this 
test strongly facilitates adequate treatment of MDR-TB 
patients, long before the results of conventional DST are 
available. Substantial reduction in the time to diagnose drug-
resistant TB, the earlier commencement of appropriate therapy 
and the potential to prevent transmission of drug-resistant 
strains constitutes the major advantages of these methods 
Because discordance still exists between the conventional and 
molecular approach of DST and susceptibility of bacteria to 
drugs is defined as inhibition of growth, we recommend that 
the GenoType® MTBDRplus test should serve as an early 
guidance of therapy, which should be followed by a 
phenotypic DST confirmation for all suspected MDR-TB 
patients. 
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